McDonnell Boehnen Hulbert & Berghoff LLP is proud to be an official sponsor of the 2015 BIO IP & Diagnostics Symposium set for September 18, 2015 in Alexandria, VA. MBHB partners Dr. Kevin Noonan and Dr. Donald Zuhn, Jr. are set to participate as featured presenters.
Session 1 (8:15-9:30 a.m.): Session 1: Strategies for Prevailing on Subject Matter Eligibility before the PTO and in Litigation
Sponsored by: McDonnell Boehnen Hulbert & Berghoff LLP
This panel will discuss the state of law and the current patent environment. Panelists will discuss overcoming challenges and strategies to work within the framework provided by the PTO and set by the courts.
Moderator:
Panelist(s):
About the BIO IP & Diagnostics Symposium
BIO’s IP & Diagnostics Symposium (BIO IPDX) will review the current patent law landscape and evaluate the impact on both the genetic diagnostics and biopharmaceutical sectors. The program will review IP issues for both diagnostics generally and companion diagnostics. The program will also explore some of the potential regulatory dimensions. BIO aims to use this event to inform industry and government alike on how to move the science forward in the current climate.
Who Should Attend?
This event is primarily geared towards patent practitioners in the life sciences, both in-house and in private practice. In-house regulatory affairs staff, licensing professionals, business development executives and regulatory agency staff seeking to understand the special premarketing and intellectual property challenges in this area would likewise benefit.
View registration details here